127 related articles for article (PubMed ID: 16118025)
1. Methylene blue photoinactivation abolishes West Nile virus infectivity in vivo.
Papin JF; Floyd RA; Dittmer DP
Antiviral Res; 2005 Nov; 68(2):84-7. PubMed ID: 16118025
[TBL] [Abstract][Full Text] [Related]
2. West Nile virus in plasma is highly sensitive to methylene blue-light treatment.
Mohr H; Knüver-Hopf J; Gravemann U; Redecker-Klein A; Müller TH
Transfusion; 2004 Jun; 44(6):886-90. PubMed ID: 15157256
[TBL] [Abstract][Full Text] [Related]
3. Methylene blue photoinactivation of RNA viruses.
Floyd RA; Schneider JE; Dittmer DP
Antiviral Res; 2004 Mar; 61(3):141-51. PubMed ID: 15168794
[TBL] [Abstract][Full Text] [Related]
4. Monocytes-macrophages are a potential target in human infection with West Nile virus through blood transfusion.
Rios M; Zhang MJ; Grinev A; Srinivasan K; Daniel S; Wood O; Hewlett IK; Dayton AI
Transfusion; 2006 Apr; 46(4):659-67. PubMed ID: 16584445
[TBL] [Abstract][Full Text] [Related]
5. West Nile virus neutralization by US plasma-derived immunoglobulin products.
Planitzer CB; Modrof J; Kreil TR
J Infect Dis; 2007 Aug; 196(3):435-40. PubMed ID: 17597458
[TBL] [Abstract][Full Text] [Related]
6. The Israeli strain IS-98-ST1 of West Nile virus as viral model for West Nile encephalitis in the Old World.
Lucas M; Frenkiel MP; Mashimo T; Guénet JL; Deubel V; Desprès P; Ceccaldi PE
Virol J; 2004 Nov; 1():9. PubMed ID: 15550172
[TBL] [Abstract][Full Text] [Related]
7. West Nile virus transmission via organ transplantation and blood transfusion - Louisiana, 2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Nov; 58(45):1263-7. PubMed ID: 19940831
[TBL] [Abstract][Full Text] [Related]
8. No evidence of West Nile virus infection in Dutch blood donors.
Koppelman MH; Sjerps MS; de Waal M; Reesink HW; Cuypers HT
Vox Sang; 2006 Apr; 90(3):166-9. PubMed ID: 16507015
[TBL] [Abstract][Full Text] [Related]
9. Highly sensitive TaqMan RT-PCR assay for detection and quantification of both lineages of West Nile virus RNA.
Tang Y; Anne Hapip C; Liu B; Fang CT
J Clin Virol; 2006 Jul; 36(3):177-82. PubMed ID: 16675298
[TBL] [Abstract][Full Text] [Related]
10. Detection of West Nile virus in the Mexican blood supply.
Sánchez-Guerrero SA; Romero-Estrella S; Rodríguez-Ruiz A; Infante-Ramírez L; Gómez A; Villanueva-Vidales E; García-Torres M; Domínguez AM; Vázquez JA; Calderón ED; Valiente-Banuet L; Linnen JM; Broulik A; Harel W; Marín Y López RA
Transfusion; 2006 Jan; 46(1):111-7. PubMed ID: 16398739
[TBL] [Abstract][Full Text] [Related]
11. A sensitive cell-based assay for the detection of residual infectious West Nile virus.
Koldijk MH; Bogaards JA; Kostense S; de Vocht M; Gijsbers L; Ter Haak M; Ophorst C; Brakenhoff JP; Weverling GJ; Guichoux JY; Uytdehaag F; Lewis J; Goudsmit J; Marzio G
Vaccine; 2007 Sep; 25(39-40):6872-81. PubMed ID: 17707954
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy in geese of a PER.C6-based inactivated West Nile virus vaccine.
Samina I; Havenga M; Koudstaal W; Khinich Y; Koldijk M; Malkinson M; Simanov M; Perl S; Gijsbers L; Weverling GJ; Uytdehaag F; Goudsmit J
Vaccine; 2007 Nov; 25(49):8338-45. PubMed ID: 17977629
[TBL] [Abstract][Full Text] [Related]
13. West Nile virus and blood product safety in Germany.
Pfleiderer C; Blümel J; Schmidt M; Roth WK; Houfar MK; Eckert J; Chudy M; Menichetti E; Lechner S; Nübling CM
J Med Virol; 2008 Mar; 80(3):557-63. PubMed ID: 18205233
[TBL] [Abstract][Full Text] [Related]
14. [Infections caused by West Nile virus].
Hermanowska-Szpakowicz T; Grygorczuk S; Kondrusik M; Zajkowska J; Pancewicz S
Przegl Epidemiol; 2006; 60(1):93-8. PubMed ID: 16758745
[TBL] [Abstract][Full Text] [Related]
15. A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity.
McDonald WF; Huleatt JW; Foellmer HG; Hewitt D; Tang J; Desai P; Price A; Jacobs A; Takahashi VN; Huang Y; Nakaar V; Alexopoulou L; Fikrig E; Powell TJ
J Infect Dis; 2007 Jun; 195(11):1607-17. PubMed ID: 17471430
[TBL] [Abstract][Full Text] [Related]
16. Virus and antibody dynamics in acute west nile virus infection.
Busch MP; Kleinman SH; Tobler LH; Kamel HT; Norris PJ; Walsh I; Matud JL; Prince HE; Lanciotti RS; Wright DJ; Linnen JM; Caglioti S
J Infect Dis; 2008 Oct; 198(7):984-93. PubMed ID: 18729783
[TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of the protective role of human antibodies to West Nile virus (WNV) produced during natural WNV infection.
Rios M; Daniel S; Dayton AI; Wood O; Hewlett IK; Epstein JS; Caglioti S; Stramer SL
J Infect Dis; 2008 Nov; 198(9):1300-8. PubMed ID: 18771407
[TBL] [Abstract][Full Text] [Related]
18. West Nile virus: recent experience with the model virus approach.
Kreil TR
Dev Biol (Basel); 2004; 118():101-5. PubMed ID: 15645678
[TBL] [Abstract][Full Text] [Related]
19. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice.
Liu WJ; Wang XJ; Clark DC; Lobigs M; Hall RA; Khromykh AA
J Virol; 2006 Mar; 80(5):2396-404. PubMed ID: 16474146
[TBL] [Abstract][Full Text] [Related]
20. West Nile virus transmission through blood transfusion--South Dakota, 2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Feb; 56(4):76-9. PubMed ID: 17268405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
